Home › GSK buys Swiss vaccine developer for $325M
 

Keywords :   


GSK buys Swiss vaccine developer for $325M

2013-05-29 18:43:57| Biotech - Topix.net

British pharma GlaxoSmithKline , which has its North American headquarters in Research Triangle Park, has acquired Swiss vaccine developer Okairos AG for about $325 million in cash.

Tags: developer swiss buys vaccine

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
03.07Summary for Hurricane Beryl (AT2/AL022024)
02.07Hurricane Beryl Graphics
02.07Hurricane Beryl Forecast Discussion Number 17
02.07Hurricane Beryl Forecast Advisory Number 17
02.07Ansell Completes Acquisition of Kimberly-Clarks PPE Business
02.07Ecolab Launches 100% Plastic-Free Wipe for Healthcare Settings
02.07Summary for Hurricane Beryl (AT2/AL022024)
02.07Chattanooga Area High School Students Graduate from BASFs TECH Academy
More »